These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8811720)

  • 1. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.
    Wadenberg ML
    Neurosci Biobehav Rev; 1996; 20(2):325-39. PubMed ID: 8811720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS; Joyce JN; Lucki I
    J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
    Deshpande LS; Khisti RT; Chopde CT
    Brain Res; 2001 Apr; 898(1):13-26. PubMed ID: 11292445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat.
    Wadenberg ML; Cortizo L; Ahlenius S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):509-13. PubMed ID: 8208768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat.
    Wadenberg ML; Ahlenius S
    Eur J Pharmacol; 1995 Dec; 294(1):247-51. PubMed ID: 8788438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties.
    Prinssen EP; Kleven MS; Koek W
    Eur J Pharmacol; 1998 Sep; 356(2-3):189-92. PubMed ID: 9774248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serotonergic agents on haloperidol-induced catalepsy.
    Hicks PB
    Life Sci; 1990; 47(18):1609-15. PubMed ID: 2250574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of presynaptic 5-HT
    Mombereau C; Arnt J; Mørk A
    Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.
    Wadenberg ML; Young KA; Richter JT; Hicks PB
    Neuropharmacology; 1999 Jan; 38(1):151-6. PubMed ID: 10193906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.
    Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH
    Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W; Neuscheler P; Nagel J; Müller CE
    Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
    Rao SG; Hrishikeshavan HJ; Guruswami MN
    Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Sonego AB; Gomes FV; Del Bel EA; Guimaraes FS
    Behav Brain Res; 2016 Aug; 309():22-8. PubMed ID: 27131780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.